Yue Alexander Wu
CIK 1682419 · last filed 2025-10-09
Yue Alexander Wu is a corporate insider who has filed 16 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for SCLXW, was dated Oct 9, 2025. Across all open-market trades the lifetime net is +$44.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.5K
3
16
$44.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SCLXW | Director | 25,000 | $0.18 | $4.5K | $19.0K | 5 | 2025-10-09 |
| CASI Pharmaceuticals, Inc. (CASI) Delisted | Director | — | $0.28 | — | $0 | 4 | 2022-05-26 |
| Sorrento Therapeutics, Inc. (SRNE) Delisted | Director | 5,000 | $0.00 | $2 | $25.8K | 7 | 2021-08-30 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-09 | SCLXW | Grant (A) | — | $0 | EDGAR |
| 2024-12-17 | SCLXW | Grant (A) | — | $0 | EDGAR |
| 2024-10-18 | SCLXW | Buy (P) | +20,000 | $19.0K | EDGAR |
| 2024-06-20 | SCLXW | Exer (M) | +5,000 | $7.0K | EDGAR |
| 2023-10-05 | SCLXW | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-30 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-16 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-18 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-15 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.